The PASTEUR Act of 2026 aims to develop innovative antimicrobial drugs, ensure their appropriate use, and combat resistance.

The PASTEUR Act of 2026 amends the Public Health Service Act to establish a program for developing innovative antimicrobial drugs targeting challenging pathogens and infections. It authorizes the Secretary of Health and Human Services to enter into contracts with sponsors of eligible antimicrobials to ensure their availability. The Act also establishes a Critical Need Antimicrobial Advisory Group to advise on the development and use of these drugs. Additionally, it creates a grant program to support hospital and other health care facilities in implementing antibiotic stewardship programs.

The PASTEUR Act of 2026 aims to develop innovative antimicrobial drugs, ensure their appropriate use, and combat resistance.

The PASTEUR Act of 2026 amends the Public Health Service Act to establish a program for developing innovative antimicrobial drugs targeting challenging pathogens and infections. It authorizes the Secretary of Health and Human Services to enter into contracts with sponsors of eligible antimicrobials to ensure their availability. The Act also establishes a Critical Need Antimicrobial Advisory Group to advise on the development and use of these drugs. Additionally, it creates a grant program to support hospital and other health care facilities in implementing antibiotic stewardship programs.